Two Sigma Securities »

Allogene Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $29k 23k 1.24
2025-06-30 $26k 23k 1.13

More positions owned by Two Sigma Securities

Ishares Core Msci Emkt (IEMG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Msci Acwi Etf (ACWI)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cme (CME)
Fox Corp Cl A Com (FOXA)
Home Depot (HD)
Ishares Tr Broad Usd High (USHY)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Capital One Financial (COF)

View all positions for Two Sigma Securities

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics